Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes

Sponsor
University of Chicago
Study ID
NCT07034261
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Gestational Diabetes

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Blinded Continuous Glucose Monitoring Device — DEVICE
    Subjects will be asked to wear blinded continuous glucose monitoring device for 14 days.

Study Details

The aim of this study is to determine the ability of postpartum continuous glucose monitoring (CGM) for subjects with gestational diabetes (GDM) to predict dysglycemia on 4-12 week postpartum oral glucose tolerance test (OGTT).

Key Dates

First listed
Jun 24, 2025
Start date
Sep 30, 2026
Status verified
Jun 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Blinded Continuous Glucose Monitoring Device
    Subjects will wear a blinded continuous glucose monitoring device.

Primary Outcome Measure

Determine the ability of continuous glucose monitoring to predict dysglycemia [ Time Frame: baseline to Day 70 ]

Central Contacts

Related Studies